Literature DB >> 13887051

Methyldopa in hypertension. Clinical and pharmacological studies.

C T DOLLERY, M HARINGTON.   

Abstract

Entities:  

Keywords:  DOPA/related compounds; HYPERTENSION/therapy

Mesh:

Substances:

Year:  1962        PMID: 13887051     DOI: 10.1016/s0140-6736(62)91781-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  35 in total

1.  [PHENOLIC ACID AND INDOLE EXCRETION IN URINE FOLLOWING ADMINISTRATION OF ALPHA-METHYLDOPA].

Authors:  W RUGE; F HARTMANN
Journal:  Klin Wochenschr       Date:  1963-09-01

2.  METHYLDOPA IN TREATMENT OF SEVERE TOXAEMIA OF PREGNANCY.

Authors:  S F HANS; H KOPELMAN
Journal:  Br Med J       Date:  1964-03-21

3.  HAEMODYNAMIC STUDIES WITH METHYLDOPA: EFFECT ON CARDIAC OUTPUT AND RESPONSE TO PRESSOR AMINES.

Authors:  C T DOLLERY; M HARINGTON; J V HODGE
Journal:  Br Heart J       Date:  1963-09

4.  METHYLDOPA AND HYDROCHLOROTHIAZIDE COMPARED WITH RESERPINE AND HYDROCHLOROTHIAZIDE IN HYPERTENSION.

Authors:  T M AGNEW; R O IRVINE; J D NORTH
Journal:  Br Med J       Date:  1963-09-28

5.  METHYLDOPA IN TREATMENT OF HYPERTENSION DUE TO CHRONIC RENAL DISEASE.

Authors:  R G LUKE; A C KENNEDY
Journal:  Br Med J       Date:  1964-01-04

6.  [The effect of intravenously administered DOPA on the blood pressure in pretreated alpha-methyl-DOPA hypertensives. Studies on the blood pressure-lowering mechanism of alpha-methyl-DOPA].

Authors:  H SCHAER; W H ZIEGLER
Journal:  Klin Wochenschr       Date:  1962-09-15

7.  Parkinsonism occurring with methyldopa treatment.

Authors:  B M GRODEN
Journal:  Br Med J       Date:  1963-04-13

8.  Bethanidine, Guanethidine, and Methyldopa in Treatment of Hypertension: a Within-patient Comparison.

Authors:  B N Prichard; A W Johnston; I D Hill; M L Rosenheim
Journal:  Br Med J       Date:  1968-01-20

9.  alpha-Methyldopa, alpha-methyldopamine an alpha-methylnoradrenaline: substrates for the thermolabile form of human platelet phenol sulphotransferase.

Authors:  G Mwaluko; R Weinshilboum
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

Review 10.  Clinical pharmacokinetics of methyldopa.

Authors:  E Myhre; H E Rugstad; T Hansen
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.